Cen Xu

Cen Xu has extensive work experience in the pharmaceutical industry. They started their career at Bristol-Myers Squibb Company in 1998 as a Sr. Research Investigator, working there until 2006. In 2006, Cen Xu joined Amgen as an Executive Medical Director and held this role for 15 years until 2021. Currently, they are the Chief Scientific Officer at AffaMed Therapeutics.

Cen Xu obtained a Doctor of Philosophy (PhD) in Pharmacology from Illinois State University in 1996.